DBV Technologies S.A. (ADR)
General ticker "DBVT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $163.3M (TTM average)
DBV Technologies S.A. (ADR) follows the US Stock Market performance with the rate: 38.8%.
Estimated limits based on current volatility of 5.5%: low 17.87$, high 19.93$
Factors to consider:
- Total employees count: 104 (+22.4%) as of 2023
- Top business risk factors: Economic downturns and volatility, Regulatory and compliance, Dependence on viaskin technology, Pandemic risks, Market competition
- Current price 302.5% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.01$, 5.80$]
- 2025-12-31 to 2026-12-31 estimated range: [1.84$, 5.16$]
Financial Metrics affecting the DBVT estimates:
- Positive: with PPE of -0.6 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -174.09 <= 0.04
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: 19.35 < Shareholder equity ratio, % of 41.71 <= 42.53
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term DBVT quotes
Long-term DBVT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $4.84MM | $15.73MM | $0.00MM |
| Operating Expenses | $101.47MM | $92.16MM | $120.53MM |
| Operating Income | $-96.63MM | $-76.43MM | $-120.53MM |
| Non-Operating Income | $0.43MM | $3.71MM | $2.73MM |
| R&D Expense | $75.54MM | $60.22MM | $89.90MM |
| Income(Loss) | $-96.20MM | $-72.72MM | $-117.80MM |
| Taxes | $0.07MM | $0.01MM | $-4.08MM |
| Profit(Loss)* | $-96.30MM | $-72.73MM | $-113.52MM |
| Stockholders Equity | $194.45MM | $140.19MM | $27.39MM |
| Inventory | $2.68MM | $0.00MM | $0.00MM |
| Assets | $246.52MM | $182.99MM | $65.66MM |
| Operating Cash Flow | $-55.70MM | $-79.65MM | $-104.47MM |
| Capital expenditure | $0.75MM | $0.68MM | $2.34MM |
| Investing Cash Flow | $-0.10MM | $-0.81MM | $-0.76MM |
| Financing Cash Flow | $194.10MM | $6.77MM | $0.59MM |
| Earnings Per Share** | $-6.22 | $-3.82 | $-5.90 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.